Axios @axios
@caitlinnowens @cathymcmorris @scrippsresearch .@cathymcmorris: "When I talk about real-time review, it was FDA that was involved on a more regular basis..giving their feedback quicker so that the delays that often take place when it comes to bringing a new breakthrough, new drug...that length of time was reduced." https://t.co/sXiCIIRoB7 — PolitiTweet.org